Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Neuroimage. 2015 Aug 8;131:102–112. doi: 10.1016/j.neuroimage.2015.08.007

Interactive effects of physical activity and APOE-ε4 on white matter tract diffusivity in healthy elders

J Carson Smith 1, Melissa A Lancaster 2,3, Kristy A Nielson 3,4, John L Woodard 5, Michael Seidenberg 2, Sally Durgerian 3, Ken Sakaie 6, Stephen M Rao 7
PMCID: PMC4746115  NIHMSID: NIHMS714467  PMID: 26265157

Abstract

Older adult apolipoprotein E epsilon 4 (APOE-ε4) allele carriers vary considerably in the expression of clinical symptoms of Alzheimer’s disease (AD), suggesting that lifestyle or other factors may offer protection from AD-related neurodegeneration. We recently reported that physically active APOE-ε4 allele carriers exhibit a stable cognitive trajectory and protection from hippocampal atrophy over 18 months compared to sedentary ε4 allele carriers. The aim of this study was to examine the interactions between genetic risk for AD and physical activity (PA) on white matter (WM) tract integrity, using diffusion tensor imaging (DTI) MRI, in this cohort of healthy older adults (ages of 65 to 89). Four groups were compared based on the presence or absence of an APOE-ε4 allele (High Risk; Low Risk) and self reported frequency and intensity of leisure time physical activity (PA) (High PA; Low PA). As predicted, greater levels of PA were associated with greater fractional anisotropy (FA) and lower radial diffusivity in healthy older adults who did not possess the APOE-ε4 allele. However, the effects of PA were reversed in older adults who were at increased genetic risk for AD, resulting in significant interactions between PA and genetic risk in several WM tracts. In the High Risk-Low PA participants, who had exhibited episodic memory decline over the previous 18-months, radial diffusivity was lower and fractional anisotropy was higher, compared to the High Risk-High PA participants. In WM tracts that subserve learning and memory processes, radial diffusivity (DR) was negatively correlated with episodic memory performance in physically inactive APOE-ε4 carriers, whereas DR was positively correlated with episodic memory performance in physically active APOE-ε4 carriers and the two Low Risk groups. The common model of demyelination-induced increase in radial diffusivity cannot directly explain these results. Rather, we hypothesize that PA may protect APOE-ε4 allele carriers from selective neurodegeneration of individual fiber populations at locations of crossing fibers within projection and association WM fiber tracts.

Keywords: Alzheimer’s disease, cognitive aging, diffusion tensor imaging, exercise, genetic risk, radial diffusivity, physical activity, white matter integrity

Introduction

The apolipoprotein-E epsilon4 (APOE-ε4) allele is the only clearly identified candidate gene for late-onset Alzheimer’s disease (AD). However, it is an imperfect predictor of who will develop clinical symptoms of the disease (Bird, 2008). The variability in clinical manifestation of AD among APOE-ε4 allele carriers suggests that other factors may offer protection from AD-related neurodegeneration and that interventions aimed at slowing or reversing AD-related processes may be effective if initiated at a much earlier stage of disease progression (Sperling et al., 2014). Identification of preclinical biomarkers that reflect increased risk from the APOE-ε4 allele may permit better prediction of future cognitive decline and development of targeted interventions (Bateman et al., 2012; Clark et al., 2008; Reiman et al., 2010; Woodard et al., 2010). Physical activity (PA), in both cross sectional and prospective studies, has been shown to protect healthy older adults against cognitive decline (Barnes & Yaffe, 2011; Etgen et al., 2010) and dementia onset (Beckett et al., 2015) and have beneficial effects on brain structure (Erickson et al., 2011) and function (Colcombe et al., 2004; Smith et al., 2013). PA has been shown to have a particularly strong protective effect among healthy older adult ε4 allele carriers, compared to non-carriers, in the maintenance of hippocampal volume (Smith et al., 2014) and cognitive function (Schuit et al., 2001; Woodard et al., 2012), protection against the accumulation of brain amyloid (Head et al., 2012), and enhancement of semantic memory network activation measured by fMRI (Smith et al., 2011). However, the neurophysiological mechanisms associated with the neuroprotective effects of PA in APOE-ε4 allele carriers have not been clearly defined.

The APOE-ε4 allele is associated with several biochemical processes that have been implicated in the etiology of AD (i.e., amyloid deposits, neurofibrillary tangle formation, neuronal cell death, oxidative stress, neuroinflammation, synaptic alterations, and cholinergic signaling dysfunction; Lane & Farlow, 2005; Poirier, 2000). White matter fiber tract integrity, as measured by diffusion tensor imaging (DTI), is a biomarker that has been shown to be compromised in AD and MCI patients. Individuals diagnosed with mild cognitive impairment and AD exhibit greater isotropic patterns of water diffusivity (i.e., lower fractional anisotropy (FA); greater mean (MD), axial (DA), and radial (DR) diffusivity) that may reflect disease-related neurodegenerative processes within neural networks (Bosch et al., 2012). In comparison, very few differences have been reported between healthy cognitively intact APOE-ε4 allele carriers and non-carriers using DTI indices of white matter integrity (Gold et al., 2010; Nyberg & Salami, 2014). The absence of large-scale differences may result from the potential moderating role of PA, which was not taken into consideration in these studies.

Greater levels of PA have been associated with greater FA and lower MD within select AD-relevant fiber tracts in healthy older adults (Johnson et al., 2012; Marks et al., 2011; Tian et al., 2014a; Tseng et al., 2013). However, the size of these effects have been relatively small and reported in only a few selected tracts, perhaps because DTI studies assessing the effects of PA did not consider genetic risk for AD as a moderating variable. The possible differential effect of PA on DTI measures of white matter fiber tract integrity in healthy older adult APOE-ε4 allele carriers and non-carriers has not been reported.

We recently published a series of papers that have examined the moderating effect of PA on indices of brain structure and brain function based on a cohort of healthy older adults who participated in a 5-year longitudinal observational study (Rao et al., 2015). We previously reported that over an 18-month period, greater levels of PA in APOE-ε4 allele carriers significantly reduced the risk for cognitive decline (Woodard et al., 2012) and preserved hippocampal volume (Smith et al., 2014) compared to physically inactive carriers. Moreover, we found that physically active APOE-ε4 allele carriers showed a greater intensity of brain activation during a semantic memory task. This increased activation also predicted stability of cognitive function over 18 months in this cohort (Woodard et al., 2010). In the current study, we examined the interactive effects of two levels of PA participation and the presence or absence of the APOE-ε4 allele on DTI indices of white matter tract integrity. These DTI data were not available at baseline but were collected 18 months after baseline, when a disproportionately greater proportion of physically inactive APOE-ε4 allele carriers had experienced cognitive decline and hippocampal atrophy relative to physically active carriers. Based on the previous literature, we hypothesized that greater PA would be related to greater FA and lower rates of radial water diffusion in white matter tracts, and that greater genetic risk would be associated with lower FA and greater rates of radial water diffusion. Furthermore, we hypothesized that these main effects of PA and genetic risk would be secondary to significant interactions between genetic risk and PA, such that PA would benefit APOE-ε4 allele carriers more than APOE-ε4 allele non-carriers.

2. Method

2.1. Participants

Healthy adults between the ages of 65 and 89 were recruited from newspaper advertisements. A telephone screen was administered initially to 459 individuals to determine eligibility based on inclusion/exclusion criteria. Potential participants were excluded if they reported a history of cognitive deterioration and/or dementia, neurological disease (cerebral ischemia, vascular headache, carotid artery disease, cerebral palsy, epilepsy, brain tumor, chronic meningitis, multiple sclerosis, pernicious anemia, normal-pressure hydrocephalus, HIV infection, Parkinson’s disease, and Huntington’s disease), medical illnesses (untreated hypertension, glaucoma, and chronic obstructive pulmonary disease), major psychiatric disturbance or substance abuse generally consistent with DSM-IV Axis I criteria or a Geriatric Depression Scale (GDS) score greater than 15. Participants were allowed to take cardiovascular drugs.

To enrich the sample with a higher percentage of APOE-ε4 carriers, half the sample was recruited based on a family history of dementia because the APOE-ε4 allele is more common in individuals with a family history of dementia than among those without such a history (Sager et al., 2005). Family history was defined as a report of a clear clinical diagnosis of AD or a reported history of gradual decline in memory and other cognitive functions, confusion, or judgment problems without a formal diagnosis of AD prior to death in a first-degree relative. As expected, a family history of AD was more common in APOE-ε4 allele carriers (n = 24; 70.6%) than non-carriers (n = 25; 46.3%) (Chi-square = 4.99; p = .026).

Of those who met criteria, 99 completed testing at the 18-month follow-up (when the current DTI pulse sequence was initiated) and had agreed to undergo APOE genotyping from blood samples, complete a PA questionnaire, be administered a brief neuropsychological and behavioral assessment, and to undergo a magnetic resonance imaging (MRI) scan session. Diffusion tensor and structural MRI scans were available from 88 of 99 (88.9%) participants. DTI data from six participants were not collected due to time constraints or the participants’ desire to end the scan session; data from three participants were lost due to technical errors and data corruption; one participant (Low Risk-High PA group) was excluded as an outlier; and one participant did not undergo the MRI scan session. From the final pool of 88 participants (87 Caucasian, 1 African American), four subgroups were formed based on the absence/presence of one or both APOE-ε4 alleles (Low Risk vs. High Risk) and self-reported frequency of leisure-time PA (Low PA vs. High PA).

This study was approved by the institutional review board at the Medical College of Wisconsin and conducted in accordance with the Helsinki Declaration. Written informed consent was obtained and all participants received modest financial compensation.

2.2. Physical Activity

Frequency and intensity of leisure time PA were measured using the Stanford Brief Activity Survey (SBAS) (Taylor-Piliae et al., 2006). There is good evidence for the reliability and validity of SBAS scores to assess habitual PA in adults and older adults. (Taylor-Piliae et al., 2010; Taylor-Piliae et al., 2007; Taylor-Piliae et al., 2006). For moderate intensity PA, the SBAS had a sensitivity of 0.73 and a specificity of 0.61 (Taylor-Piliae et al., 2006). Participants who endorsed one of the two items indicating two or fewer days of low intensity PA (ranging from no PA to slow walking or light chores) were classified as physically inactive (Low PA). Participants endorsing one of the remaining three items describing moderate to vigorous intensity PA three or more days per week (ranging from brisk walking, jogging or swimming for 15 minutes or more, or moderately difficult chores for 45 minutes, to regular jogging, running, bicycling or swimming for 30 minutes or more, or playing sports such as handball or tennis for an hour or more) were classified as physically active (High PA)(Smith et al., 2011; Smith et al., 2014; Woodard et al., 2012).

2.3. Genetic Testing

APOE genotype was determined using a polymerase chain reaction method (Saunders et al., 1996). Deoxyribonucleic acid was isolated with Gentra Systems Autopure LS for Large Sample Nucleic Acid Purification. Participants with one or both APOE-ε4 alleles were classified as High Risk for developing AD and the remainder classified as Low Risk. APOE genotype results for the four groups were as follows: Low Risk-High PA (n=21: 3 ε2/ε3 and 18 ε3/ε3), Low Risk-Low PA (n=33: 5 ε2/ε3 and 28 ε3/ε3), High Risk-High PA (n= 20 18 ε3/ε4 and 2 ε4/ε4), and High Risk-Low PA (n=14: 1 ε2/ε4 and 13 ε3/ε4).

2.4. Neuropsychological Testing

Cognitive functioning was determined from a neuropsychological test battery (Woodard et al., 2009) consisting of the Mini Mental State Examination (MMSE; Folstein et al., 1975), Mattis Dementia Rating Scale, 2nd Edition (DRS-2; Jurica et al., 2001), and the Rey Auditory Verbal Learning Test (RAVLT; Rey, 1958), measures commonly used to assess general cognitive status and anterograde memory impairment. In addition, the Geriatric Depression Scale (GDS) (Yesavage, 1988) and Lawton Activities of Daily Living (ADL) scale (Lawton & Brody, 1969) were both administered along with the neuropsychological assessments.

2.5. Data Collection

Participants underwent reviews of their medical and psychosocial history, completed the neuropsychological test battery (MMSE, DRS-2, RAVLT, GDS, ADL), and underwent functional and structural MRI scanning at baseline and 18 months. Only data from the 18-month follow-up are reported here since the DTI scans were collected only during this examination. We incorporated the baseline neuropsychological testing to calculate the number of participants who experienced a significant cognitive decline over the previous 18-month follow-up (for details, see Woodard et al., 2012).

2.5.1. Structural Image Acquisition

DTI and high-resolution anatomical images were collected on a General Electric (Waukesha, WI) Signa Excite 3.0 Tesla short bore scanner at Froedtert Hospital (Milwaukee, WI). Foam padding was used to reduce head movement within the coil. High-resolution anatomical scans were obtained from a three-dimensional spoiled gradient-recalled at steady-state (SPGR) pulse sequence (TE = 3.9 ms; TR = 9.5 ms; inversion recovery (IR) preparation time = 450 ms; flip angle = 12 degrees; number of excitations (NEX) = 2; slice thickness = 1.0 mm; field of view (FOV) = 24 cm; resolution = 256 × 224; slices = 144).

2.5.2. Diffusion Tensor Imaging

Whole brain (35 axial slices; 4 mm) diffusion tensor images were acquired with 25 encoding directions (b = 1000 s/mm2; TE = min (86.5ms); TR = 10, 000 ms; FOV = 240 mm, matrix = 128 × 128; acquisitions = 1). Images were smoothed at 6 mm FWHM to eliminate Gibbs ringing. Head movement and eddy currents were corrected and the Brain Extraction Tool (BET; Smith, 2002) was applied to exclude non-brain voxels. Each diffusion-weighted image was registered to the corresponding b0 image (no diffusion encoding). Fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (DA), and radial diffusivity (DR) images were created by fitting a tensor model to the raw diffusion data using the FSL Diffusion Toolbox (Behrens et al., 2003).

2.6. DTI Processing Methods

DTI data were first processed using the Tract-Based Spatial Statistics (TBSS Smith et al., 2006) program found in FSL 4.0 image processing software (http://www.fmrib.ox.ac.uk/fsl/tbss/index.html) to create a mean white matter skeleton. Specifically, all FA images were aligned to the FMRIB58 standard image in cubic 1 mm standard space. FA images were averaged and a skeleton created with an FA threshold of 0.2 representing tracts common to all participants. This method of “thinning” each white matter tract perpendicular to the tract and applying a threshold for FA helps to eliminate the threat of partial volume effects and areas of high inter-subject variability (Smith et al., 2006). Each participant’s maximum FA value from the nearest relevant tract center was assigned to the corresponding skeleton voxel, which corrects for residual misalignments after nonlinear registration. Diffusivity measures from the same maximum FA voxels were also assigned to the corresponding skeleton voxels.

Following the creation of the FA skeleton, white matter tracts of interest were created using the ICBM DTI-81 white matter atlas (Mori et al., 2008). The atlas consists of 48 white matter tracts based on acceptable levels of intra- and inter-rater reliability. Using the Analysis of Functional NeuroImages (AFNI) software package (Cox, 1996), the TBSS-derived FA skeleton was overlaid onto the ICBM DTI-81 atlas. From this conjunction map, mean FA, MD, DA, and DR values were calculated for each subject for each of 25 white matter tracts of interest. Figure 1 shows the 25 tracts of interest investigated as represented in the ICBM DTI-81 atlas. Data were screened and outliers greater than three standard deviations from the mean were removed (< 1% of data).

Figure 1.

Figure 1

(Top) Axial (inferior to superior from left to right), coronal (rostral to caudal from left to right), and sagittal (left hemisphere to right hemisphere from left to right) views of the white matter fiber tract mask that was created, from which the DTI data were extracted and compared in the statistical analysis. The colors of each tract represent each of the bilateral or midline fiber tracts of interest based on the ICBM DTI-81 white matter atlas (Mori et al., 2008); anatomical labels for the tracts are listed in Table 2. (Bottom) Axial (inferior to superior from left to right), coronal (rostral to caudal from left to right), and sagittal (left hemisphere to right hemisphere from left to right) views of the significant interactions between genetic risk and physical activity for radial diffusivity, shown in orange. White matter tracts with non-significant interaction effects for radial diffusivity are shown in blue.

2.7. Statistical Analysis

FA, MD, DA, and DR values from each WM tract were subjected to a 2 (High Risk vs. Low Risk) × 2 (High PA vs. Low PA) analysis of variance (ANOVA; SPSS 21, Chicago, IL), with age at the time of the scan as a covariate. Significant effects were followed by post-hoc group comparisons with the False Discovery Rate (FDR) threshold used to control the family-wise error rate with significance at p < .05.

3. Results

3.1 Participant characteristics and cognitive status

Demographic characteristics, neuropsychological test scores, cognitive trajectory over the past 18-months, symptoms of depression, and activities of daily living are presented for the four participant groups (Low Risk-High PA, n = 21; Low Risk-Low PA, n = 33; High Risk-High PA, n = 20; High Risk-Low PA, n = 14) in Table 1. The groups were not significantly different in age, education, or sex, and were similar in symptoms of depression and activities of daily living. As reported in our prior work (Woodard et al., 2010; Woodard et al., 2012), all participants were determined to be cognitively intact at the baseline assessment conducted 18 months prior to the data presented in the current study. As reported in our prior publications (Woodard et al., 2010; Woodard et al., 2012), the High Risk-Low PA group had a greater proportion of participants who declined by more than 1 SD on either the RAVLT immediate recall, RAVLT delayed recall or the DRS total score compared to the High Risk-High PA group and high and low PA non-carriers.

Table 1.

Participant Characteristics (mean ±SD; N = 88) and summary result of the 2 (Risk) × 2 (PA) between-groups ANOVAs.

Variables Low Risk High Risk Interaction p Interaction η2
High PA (n = 21) Low PA (n = 33) High PA (n = 20) Low PA (n = 14)
Demographics
Age (yrs) 76.0 (4.7) 73.5 (4.7) 73.1 (4.4) 74.0 (4.2) 0.10 0.03
Education (yrs) 14.8 (2.7) 14.0 (2.0) 15.4 (3.2) 15.6 (3.1) 0.45 <0.01
Sex 6M, 15F 7M, 26F 5M, 15F 5M, 9F 0.37 0.01
Neuropsychological Testing
MMSE 29.5 (0.9) 29.6 (1.0) 29.4 (1.1) 28.7 (1.1) 0.10 0.03
DRS Total 138.1 (2.6) 139.2 (2.1) 137.1 (4.0) 137.8 (3.7) 0.72 <0.01
AVLT Trials 1–5 46.1 (6.4) 48.9 (7.3)a 46.2 (8.5) 41.6 (8.9)a 0.04 0.05
AVLT IR 9.2 (2.1) 10.2 (2.6)a 9.4 (3.2)b 7.2 (2.7)a,b 0.01 0.08
AVLT DR 9.0 (2.5)b 10.0 (2.9)a 8.8 (3.4)c 6.1 (2.6)a,b,c 0.01 0.09
Prior 18-Month Cognitive Trajectory
Declined > 1 SD (#, %) 6, 28 8, 24 6, 30 11, 79 <0.01
Depression Symptoms and Activities of Daily Living
GDS 1.8 (2.4) 2.5 (2.5) 3.0 (2.5) 1.7 (2.7) 0.07 0.04
Lawton ADL 5.0 (0.0) 4.9 (0.2) 4.9 (0.3) 4.9 (0.3) 0.53 <0.01

Notes: All neuropsychological indices represent raw scores. Common superscript within each variable indicates significant differences between groups (p < .05, FDR-corrected);

b

= p < .05, but does not survive FDR threshold for significance.

High Risk = APOE-ε4 allele carrier; PA = Physical Activity; M = male; F = female; MMSE = Mini-Mental State Exam; DRS = Mattis Dementia Rating Scale; AVLT = Rey Auditory Verbal Learning Test; DR = Delayed Recall; GDS = Geriatric Depression Scale; ADL = Activities of Daily Living.

3.2 Interactions between genetic risk and physical activity

Table 2 indicates that significant 2 (Risk) × 2 (PA) interactions were observed for FA in 13 tracts: three long association (superior longitudinal fasciculus, bilateral sagittal stratum), four limbic association (bilateral cingulum, bilateral fornix/stria terminalis), and six projection (bilateral anterior limb of the internal capsule, bilateral anterior corona radiata, left posterior corona radiata, and left superior corona radiata). Inspection of the interaction revealed that within the Low Risk groups, FA was greater in the Low Risk-High PA compared to the Low Risk-Low PA group. However, the opposite pattern was observed in the High Risk groups: FA was lower in the High Risk-High PA compared to the High Risk-Low PA group. Figure 2 displays mean FA values for each group in four (of 13) representative tracts in which there was a significant interaction between genetic risk and PA. The mean FA values for each group and the contrasts between groups for FA are shown in Supplemental Table 1.

Table 2.

Interaction effects (2 Physical Activity (High, Low) × 2 APOE-ε4 Risk (High, Low) for Diffusion Tensor Imaging measures within 25 white matter fiber tracts.

WM Tract Fractional Anisotropy (FA) Mean Diffusivity (MD) Axial Diffusivity (DA) Radial Diffusivity (DR)
FA Int. p FA Int. η2 MD Int. p MD Int. η2 DA Int. p DA Int. η2 DR Int. p DR Int. η2
Long Assoc.
SLF, left .0016 .113 .0013 .119 ns - .0005 .138
SLF, right .0443 .048 .0020 .110 .0177 .066 .0025 .106
SS, left <.0001 .194 .0027 .104 ns - .0001 .167
SS, right .0005 .138 .0036 .099 ns - .0003 .146
UNC, left ns - ns - ns - .0499 .046
UNC, right .0340 .053 ns - ns - ns -
Limbic Assoc.
CGC, left .0033 .099 .0130 .072 ns - .0006 .135
CGC, right .0092 .079 .0096 .078 ns - .0026 .104
CGH, left .0379 .051 ns - ns - ns -
CGH, right .0438 .048 ns - ns - .0255 .059
FxS, left .0206 .063 ns - ns - ns -
FxS, right .0042 .095 .0411 .049 ns - .0026 .105
Commissural
BCC ns - ns - ns - ns -
GCC .0450 .048 ns - ns - ns -
SCC ns - .0404 .050 ns - ns -
Projection
ALIC, left <.0001 .198 .0138 .071 ns - .0013 .117
ALIC, right .0002 .158 .0408 .051 ns - .0051 .093
PLIC, left ns - .0375 .052 ns - ns -
PLIC, right ns - ns - ns - ns -
ACR, left .0001 .180 .0218 .063 ns - .0030 .103
ACR, right .0001 .171 .0199 .064 ns - .0043 .095
PCR, left .0070 .084 .0380 .052 ns - .0222 .063
PCR, right .0410 .050 .0136 .073 .0479 .047 .0117 .076
SCR, left .0245 .059 .0006 .135 ns - .0004 .142
SCR, right .0370 .051 .0003 .148 .0167 .067 .0004 .143

Note: Values in bold italics exceed the false discovery rate (FDR) threshold for significance; other values are p < .05 but did not meet the FDR threshold; ns = not significant; η2 = partial eta-squared; ACR = anterior corona radiata; ALIC = anterior limb of internal capsule; BCC = body of corpus callosum; CGC = cingulum (cingulate gyrus); CGH = cingulum - hippocampal projection; FxS = fornix (cres)/Stria terminalis; GCC = genu of corpus callosum; PCR = posterior corona radiate; PLIC = posterior limb of internal capsule; SCC = splenium of corpus callosum; SCR = superior corona radiata; SLF = superior longitudinal fasciculus; SS = sagittal stratum (includes inferior longitudinal fasciculus and inferior fronto-occipital fasciculus); UNC = uncinate fasciculus.

Figure 2.

Figure 2

(Left) Fractional anisotropy in the four groups of participants within the four WM tracts that had the largest Risk × PA interaction effects. (Right) Radial diffusivity (mm2/sec) in the four groups of participants within the four WM tracts that had the largest Risk × PA interaction effects. Error bars are the SEM.

Table 2 also presents significant 2 (Risk) × 2 (PA) interactions for MD in 12 tracts: four long association (bilateral superior longitudinal fasciculus, bilateral sagittal stratum), two limbic association (bilateral cingulum) and six projection (left anterior limb of the internal capsule, bilateral anterior corona radiata, right posterior corona radiata, and bilateral superior corona radiata). Analysis of the interactions revealed that within the Low Risk groups, MD was lower in the Low Risk-High PA compared to the Low-Risk-Low PA group. However, the opposite pattern was observed in the High Risk groups; MD was greater in the High Risk-High PA compared to the High Risk-Low PA group. The mean MD values for each group and the contrasts between groups for MD are shown in Supplemental Table 2.

No significant 2 (Risk) × 2 (PA) interactions were observed for DA. Three tracts (left superior longitudinal fasciculus, right posterior corona radiata, and right superior corona radiata) reached p < .05, but did not survive the FDR threshold to control for multiple comparisons (Table 2). The mean DA values for each group and the contrasts between groups for DA are shown in Supplemental Table 3.

Table 2 indicates that there were 16 tracts that demonstrated significant 2 (Risk) × 2 (PA) interactions for DR: four long association (bilateral superior longitudinal fasciculus, bilateral sagittal stratum), four limbic association (bilateral cingulum-cingulate, right cingulum-hippocampal projection; right fornix/stria terminalis), and eight projection (bilateral anterior limb of the internal capsule, bilateral anterior corona radiata, bilateral posterior corona radiata, and bilateral superior corona radiata)(see). Analysis of the interactions revealed that within the Low Risk groups, DR was lower in the Low Risk-High PA compared to the Low Risk-Low PA group. However, the opposite pattern was observed in the High Risk groups; DR was greater in the High Risk-High PA compared to the High Risk-Low PA group. The mean DR values for each group and the contrasts between groups for DR are shown in Supplemental Table 4.

The overall pattern of the interaction effects suggests that group differences in DR, coupled with the overall lack of group differences in DA, were driving the interaction effects for MD and FA (which are a function of the axial diffusivity eigenvector that defines DA and the two radial diffusivity eigenvectors that define DR). Figure 2 displays the DR values for each group in four (of 16) representative tracts in which there was a significant interaction between genetic risk and PA.

3.3 Main effects of genetic risk

No statistically significant main effects of genetic risk were observed on FA or DA in any of the 25 WM fiber tracts (Supplemental Tables 1 and 3, respectively). There were significant main effects of genetic risk on MD in six projection tracts (bilateral anterior limb of the internal capsule, left posterior limb of the internal capsule, bilateral posterior corona radiata, and left superior corona radiata; Supplemental Table 4). There were significant main effects of genetic risk on DR in four projection tracts (right anterior limb of the internal capsule, bilateral posterior corona radiata, and left superior corona radiata; Supplemental Table 4). For each significant main effect, the low risk groups had greater MD and DR values compared to the High Risk groups (see Supplemental Tables 2 and 4 for post-hoc comparisons).

3.4 Main effects of physical activity

One significant main of effect of PA for FA was seen within the left fornix/stria terminalis, indicating greater FA on average in the Low PA groups. The only statistically significant post-hoc comparison indicated FA was greater in the High Risk-Low PA group compared to the High Risk-High PA group (Supplemental Table 1). There were no significant main effects of PA for MD (Supplemental Table 2), DA (Supplemental Table 3) or DR (Supplemental Table 4).

3.5 Associations between mean diffusivity and episodic memory performance

In order to shed light on the unexpected direction of the DR interactions between genetic risk and physical activity, we conducted a post-hoc analysis to determine if there were differences between the groups in the relationship between DR and cognitive function. Because the effect of PA on DR was in the opposite direction than hypothesized in the two high risk groups, we focused the analysis on the comparisons between the high and low PA groups within each of the two risk groups. Pearson correlation coefficients were computed between DR and AVLT Trials 1–5, AVLT immediate recall, and AVLT delayed recall scores in each of the 25 WM tracts. The resulting magnitudes of the correlations between DR and the AVLT scores were directly compared (using Fisher’s r to z transformation) between the High PA and Low PA groups within each APOE risk group, and the FDR threshold was applied to determine the statistical significance of each group comparison. We hypothesized that radial diffusivity would be negatively correlated with episodic memory performance in each group (greater DR associated with lower episodic memory performance), but that the magnitude of the negative correlations would be attenuated in the High Risk-Low PA group compared to their High PA counterparts.

As expected, the low risk groups demonstrated significant negative correlations between DR and AVLT performance and no significant differences were observed between High PA and Low PA groups in terms of the magnitude of the correlations between DR and AVLT scores. In the Low Risk-High PA group, there were significant negative correlations between DR and AVLT immediate recall in the left cingulum bundle (r = −.38, p = .04), left cingulum-hippocampal tract (r = −.48, p = .03), and body of the corpus callosum (r = −.50, p = .02); in the Low Risk-Low PA group, there were significant negative correlations between DR and AVLT delayed recall score in the left and right anterior limb of the internal capsule (r = −.38, p = .04; r = −.37, p = .04, respectively), the right superior corona radiata (r = −.41, p = .02), and the genu of the corpus callosum (r = −.347, p = .05). Similarly, in the High Risk-High PA group, there were significant negative correlations between DR and AVLT immediate recall performance in the left and right longitudinal fasciculus and left and right sagittal stratum (r = −.48, p = .03; r = −.46, p = .04, respectively), the posterior limb of the internal capsule (r = −.53, p = .02) and the splenium of the corpus callosum (r = −.51, p = .02).

In contrast, within the high risk groups there were eight WM tracts in which the correlations between DR and the AVLT delayed recall score were significantly different between the High PA and Low PA groups (bilateral ALIC, bilateral CGC, bilateral FxS, right SLF and right PLIC; all met FDR threshold, p < .01, one-tailed). As shown in Figure 3, there were significant positive correlations between DR and AVTL delayed recall score in the High Risk-Low PA group compared to the negative or near zero correlations in the High Risk-High PA group, and the group differences in the correlation coefficients were statistically significant (FDR-corrected for multiple comparisons). A similar pattern emerged when comparing correlations between DR and AVLT immediate recall score in the two High Risk groups (three comparisons, not shown, met the FDR threshold; bilateral CGC and right SLF, all p < .005, one-tailed).

Figure 3.

Figure 3

Scatter plots and fitted linear regression lines showing the relationships between radial diffusivity and Rey Auditory Verbal Learning Test delayed recall performance in the High Risk-Low PA (red squares) and High Risk-High PA (blue circles) groups in eight white matter fiber tracts. In each fiber tract, the difference in the magnitude of the correlation was significantly different between the groups (FDR-corrected, p < .05). An asterisk indicates that the correlation was significant (p < .05) compared to 0.

4. Discussion

4.1 Interactions between genetic risk and physical activity participation

Based on previous studies that have reported stronger effects of PA on cognition, risk for cognitive decline, and hippocampal atrophy among APOE-ε4 allele carriers, we hypothesized that the effects of PA on DTI metrics would be greater in the APOE-ε4 allele carriers compared to non-carriers. While this hypothesis was supported, the results were not in the expected direction. Participants at greater genetic risk who reported engaging in greater amounts of PA had lower FA and greater diffusivity in several WM tracts compared to their physically inactive APOE-ε4 allele carrying counterparts. The group differences in FA and MD, together with the lack of group differences in DA, indicate these effects are primarily driven by the group differences in DR (Acosta-Cabronero et al., 2010).

Increased radial diffusivity has been observed in AD patients (Bosch et al., 2012), and has been hypothesized to reflect axonal demyelination (Song et al., 2002). However, this proposed mechanism does not explain the greater radial diffusivity we observed in healthy physically active compared to physically inactive ε4 carriers and it is not consistent with their cognitive trajectory. Our previous reports from a subsample of this cohort indicated that over the 18 months prior to the current study, the physically active ε4 carriers were less likely to decline on tests of episodic memory function (Woodard et al., 2012) and displayed maintenance of hippocampal volume that was comparable to ε4 non-carriers (Smith et al., 2014). Moreover, the physically active ε4 carriers had greater semantic memory-related activation compared to the group of physically inactive ε4 carriers (Smith et al., 2011), which we have shown to predict cognitive stability over 18 months (Woodard et al., 2010). This pattern of activation appears to reflect a successful neural compensatory response over 5 years (Rao et al., 2015). In contrast, the combination of being physically inactive and at increased genetic risk for AD, despite being cognitively intact with normal hippocampal volumes at baseline, resulted in greater probability of cognitive decline and hippocampal atrophy over 18-months (Smith et al., 2014; Woodard et al., 2012). These interactive effects between PA and APOE genotype have also been reported for brain amyloid accumulation in healthy older adults, as measured by PET and CSF biomarkers, with only the physically inactive ε4 carriers showing a substantial amyloid burden (Head et al., 2012). The common thread among these studies is that PA appears to moderate the effect of the APOE-ε4 allele and results in normalization of the biomarker for AD progression, with the physically active ε4 carriers more closely resembling those at low genetic risk in both their cognitive trajectory and brain structural profile. However, being a physically inactive APOE-ε4 allele carrier appears to substantially increase the likelihood for cognitive decline and neurodegeneration.

The overall pattern of our results indicates that the radial diffusivity in the High Risk-High PA group was more similar to the Low Risk groups. Clues to the meaning of these results lie within the High Risk-Low PA group, who showed unexpectedly low radial diffusivity compared to the other groups. One possible explanation is that there were fewer crossing fibers within these WM tracts in the High Risk-Low PA group. Crossing fibers are known to be more prominent in projection fiber tracts such as the superior corona radiata and the presence of more crossing fibers leads to greater values for radial diffusivity using scalar diffusion weighted imaging metrics (Pierpaoli et al., 2001). The loss of crossing fibers in these WM tracts due to a neurodegenerative process may result in a reduction in radial diffusivity and increased FA, possibly resulting in lesser structural and functional connectivity within the affected neural networks (Pierpaoli et al., 2001). This selective neurodegenerative effect, leading to greater FA, has been demonstrated in AD and MCI patients compared to healthy controls within the centrum semiovale (which is continuous with the superior corona radiata) where there are more crossing fibers, but not the corpus callosum, where white matter fiber direction is more uniform (Douaud et al., 2011). Our observed interaction effects were restricted to long association, limbic association, and projection fiber tracts, where crossing fibers are more likely to be present. Two of the largest interaction effects for DR were observed in the superior corona radiata (see Table 2 and Figure 2), consistent with the results reported by Douaud and colleagues. Importantly, there were no significant differences between the groups within the commissural fiber tracts or for axial diffusivity in any of the WM tracts. These effects are consistent with selective degenerative processes that preserve the tract along its primary longitudinal axis (Douaud et al., 2011). The relationships we observed between radial diffusivity and episodic memory performance support this interpretation.

In the low risk participants, and among the physically active ε4 carriers, greater radial diffusivity was associated with lower word list learning performance, as might be expected. However, in the High Risk-Low PA group, this association was reversed, and greater radial diffusivity was associated with greater delayed and immediate recall performance on the AVLT. Thus, it is plausible that the significantly lower cognitive performance in the High Risk-Low PA group is related to the loss or thinning of crossing WM fibers within WM tracts that serve cortical and hippocampal regions involved in episodic memory encoding and retrieval. These findings require replication using animal models and human studies with higher resolution DTI sequences that would more accurately determine WM crossing fiber differences between physically active and physically inactive ε4 carriers.

4.2 Main effects for genetic risk

We found very little evidence for overall differences in WM diffusivity between APOE-ε4 carriers and non-carriers (see Supplemental Tables). In the current study, the main effects for genetic risk were small and limited to a few fiber tracts for MD and DR. However, these effects were in the opposite direction as would be predicted due to the interactions with PA in the high-risk groups and many did not survive correction for multiple comparisons. Several previous studies have compared DTI measures between older adults at low versus high genetic risk for AD and found mixed findings. Some studies report lower FA and/or greater diffusivity among APOE-ε4 carriers versus non-carriers (Dowell et al., 2013; Gold et al., 2010; Heise et al., 2011; Nierenberg et al., 2005; Persson et al., 2006; Smith et al., 2010), while others report no differences between these groups (Bendlin et al., 2010; Honea et al., 2009; Matura et al., 2014; Nyberg & Salami, 2014; O’Dwyer et al., 2012; Patel et al., 2013). It is possible that these mixed reports, and the relatively limited effects that have been reported, are because the moderating influence of PA and its potential interactive effects with APOE genotype have not been considered.

4.3 Main effects for physical activity

Previous studies in healthy older adults have reported that greater cardiorespiratory fitness was associated with higher FA in the cingulum bundle (Marks et al., 2011; Marks et al., 2007; Tian et al., 2014b), uncinate fasciculus (Marks et al., 2007), and corpus callosum (Johnson et al., 2012), and lower mean and radial diffusivity in the entorhinal cortex (Tian et al., 2014b) and corpus callosum (Johnson et al., 2012), respectively. One exercise training study found that increased cardiorespiratory fitness in the walking intervention group, but not in the stretching control group, was associated with greater FA in the frontal WM tracts (Voss et al., 2012). In another study, master athletes (mean age 72 yrs with more than 15 yrs endurance training) had higher FA values compared to sedentary older adults in the right superior corona radiata, bilateral superior longitudinal fasciculus, right inferior fronto-occipital fasciculus, and left inferior longitudinal fasciculus, and lower MD values in the left posterior thalamic radiation and left cingulum hippocampus tract (Tseng et al., 2013). Self-reported PA in healthy older adults has been associated with lower MD in the medial temporal lobe and cingulate cortex (Tian et al., 2014a).

In all of these previously published studies, the influence of the APOE-ε4 allele was not reported. When the presence or absence of the APOE-ε4 allele was taken into consideration in the current study, the large interaction effects between genetic risk and PA superseded the main effects of PA. However, comparison between only the two low risk groups reveals that the effects of PA were consistent with the prior literature. The Low Risk-High PA group, compared to the Low Risk-Low PA group, had significantly greater FA in the left sagittal stratum, bilateral anterior limb of the internal capsule, and along nearly the entire corona radiata (Supplemental Table 1). For WM diffusivity, the Low Risk-High PA participants had lower DR in the bilateral superior longitudinal fasciculus, sagittal stratum, cingulum, anterior limb of the internal capsule, and the posterior and superior corona radiata (Supplemental Table 4), which were mirrored in the effects on MD (Supplemental Table 2). In contrast, the directions of the main effects of PA were reversed in the higher risk groups. Finally, in this study and in previous studies, few if any effects of PA or fitness have been found for axial diffusivity.

4.5 Potential mechanisms

There are several potential neurophysiological mechanisms for exercise and PA to protect brain structure and function in old age. PA is well known for its neurotrophic effects in rodents that support neurogenesis in the dentate gyrus (Trejo et al., 2001; van Praag et al., 2005), effects likely to occur in humans as well (Erickson et al., 2011; Pereira et al., 2007). Exercise has been shown to improve cholinergic function and to oppose the actions of acetylcholinesterase in the hippocampus and cerebral cortex of rats (Ben et al., 2009). In addition, cholinergic enhancement due to PA may increase cerebral blood flow, enhance neural activation, and possibly reduce amyloid burden (Adlard et al., 2005; Head et al., 2012). The neuroprotective mechanisms of PA specific to WM integrity in ε4-carriers are less well understood. Rodent studies suggest PA counteracts the physiologic impact of the APOE-ε4 allele, and the resultant reduction in availability of apolipoprotein E, through improved brain lipid metabolism, reduced neuroinflammation, and/or augmented cholinergic function (Intlekofer & Cotman, 2013). Exercise in ε4 mice leads to normalization of tyrosine kinase B receptors, which have a high affinity for BDNF (Nichol et al., 2009) and to increased anti-inflammatory cytokines (Fukao et al., 2010). The selective sparing of WM tracts in the current study may also be related to exercise-induced spinogenesis and/or dendritic branching along axons (Eadie et al., 2005), which is compromised by the APOE-ε4 allele in mouse models of AD (Dumanis et al., 2009).

4.6 Limitations

This study is limited by its cross sectional design. A causal pathway between PA and WM diffusivity cannot be determined until a randomized controlled trial is conducted to compare the effects of exercise training on changes in white matter diffusivity between APOE-ε4 allele carriers and non-carriers. Unfortunately, we were not able to obtain DTI data at the baseline session 18-months before the current data were collected. It will be important for future studies to track the longitudinal changes in WM integrity as a function of both genetic risk and PA behavior, to consider the independent role of family history for AD, and to determine if these effects extend beyond our predominantly Caucasian sample. As noted in our previous work, this study is also limited by the use of self-reported leisure-time PA, rather than an objective measurement of cardiorespiratory fitness, such as the maximal rate of oxygen consumption (VO2max). The SBAS, however, has been shown in large samples to be associated with estimated caloric expenditure during PA and to be dose-dependently related to cardiovascular risk biomarkers (Taylor-Piliae et al., 2006).

4.7 Conclusions

Consistent with previous studies in healthy older adults, greater levels of PA were associated with greater FA and lower radial diffusivity within association and projection WM tracts in healthy older adults who did not possess the APOE-ε4 allele. However, these effects of PA were reversed in older adults who were at increased genetic risk for AD and who had exhibited episodic memory decline over the past 18-months. In less physically active and genetically at risk individuals, radial diffusivity was lower compared to those with greater levels of leisure time physical activity who also possessed the APOE-ε4 allele. Moreover, in several tracts that serve learning and memory processes, lower radial diffusivity was significantly correlated with lower episodic memory performance in the physically inactive at-risk group. While it is possible that PA may protect myelin and thus reduce radial diffusion, our findings call into question the common interpretation that greater radial diffusivity inevitably reflects demyelination and neurodegeneration. We hypothesize that PA may specifically protect APOE-ε4 allele carriers against the selective loss of white matter fibers in projection and association WM tracts, and furthermore, that physical inactivity may exacerbate the APOE-ε4 related processes associated with degeneration of individual populations of white matter fibers in locations of crossing fibers. This hypothesis should be confirmed using more advanced diffusion weighted imaging methods and randomized controlled exercise trials in humans. In addition, animal models should be used to explore the mechanisms for these potential neuroprotective effects of physical activity in APOE-ε4 allele carriers.

Supplementary Material

1
2

Acknowledgments

This project was supported by NIH grant R01-AG022304. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Aging or the National Institutes of Health.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer’s disease. Brain. 2010;133(Pt 2):529–539. doi: 10.1093/brain/awp257. [DOI] [PubMed] [Google Scholar]
  2. Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J Neurosci. 2005;25(17):4217–4221. doi: 10.1523/JNEUROSCI.0496-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. The Lancet Neurology. 2011;10:819–828. doi: 10.1016/S1474-4422(11)70072-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease. N Engl J Med. 2012 doi: 10.1056/NEJMoa1202753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beckett MW, Ardern CI, Rotondi MA. A meta-analysis of prospective studies on the role of physical activity and the prevention of Alzheimer’s disease in older adults. BMC Geriatr. 2015;15(1):9. doi: 10.1186/s12877-015-0007-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Behrens MW, Woolrich M, Jenkinson H, Johansen-Berg RG, Nunes S, Clare PM. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med. 2003;50:1077–1088. doi: 10.1002/mrm.10609. [DOI] [PubMed] [Google Scholar]
  7. Ben J, Soares FM, Cechetti F, Vuaden FC, Bonan CD, Netto CA, Wyse AT. Exercise effects on activities of Na(+),K(+)-ATPase, acetylcholinesterase and adenine nucleotides hydrolysis in ovariectomized rats. Brain Res. 2009;1302:248–255. doi: 10.1016/j.brainres.2009.09.013. [DOI] [PubMed] [Google Scholar]
  8. Bendlin BB, Ries ML, Canu E, Sodhi A, Lazar M, Alexander AL, Carlsson CM, Sager MA, Asthana S, Johnson SC. White matter is altered with parental family history of Alzheimer’s disease. Alzheimers Dement. 2010;6(5):394–403. doi: 10.1016/j.jalz.2009.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bird TD. Genetic aspects of Alzheimer disease. Genet Med. 2008;10(4):231–239. doi: 10.1097/GIM.0b013e31816b64dc. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bosch B, Arenaza-Urquijo EM, Rami L, Sala-Llonch R, Junque C, Sole-Padulles C, Pena-Gomez C, Bargallo N, Molinuevo JL, Bartres-Faz D. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol Aging. 2012;33(1):61–74. doi: 10.1016/j.neurobiolaging.2010.02.004. [DOI] [PubMed] [Google Scholar]
  11. Clark CM, Davatzikos C, Borthakur A, Newberg A, Leight S, Lee VM, Trojanowski JQ. Biomarkers for early detection of Alzheimer pathology. Neurosignals. 2008;16(1):11–18. doi: 10.1159/000109754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Colcombe SJ, Kramer AF, Erickson KI, Scalf P, McAuley E, Cohen NJ, Webb A, Jerome GJ, Marquez DX, Elavsky S. Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci U S A. 2004;101(9):3316–3321. doi: 10.1073/pnas.0400266101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cox R. AFNI: sotware for analysis and visualization of functional magnetic resonance images. Computers and Biomedical Research. 1996;29:162–173. doi: 10.1006/cbmr.1996.0014. [DOI] [PubMed] [Google Scholar]
  14. Douaud G, Jbabdi S, Behrens TE, Menke RA, Gass A, Monsch AU, Rao A, Whitcher B, Kindlmann G, Matthews PM, Smith S. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer’s disease. Neuroimage. 2011;55(3):880–890. doi: 10.1016/j.neuroimage.2010.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dowell NG, Ruest T, Evans SL, King SL, Tabet N, Tofts PS, Rusted JM. MRI of carriers of the apolipoprotein E e4 allele-evidence for structural differences in normal-appearing brain tissue in e4+ relative to e4-young adults. NMR Biomed. 2013;26(6):674–682. doi: 10.1002/nbm.2912. [DOI] [PubMed] [Google Scholar]
  16. Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, Ladu MJ, Weeber EJ, Turner RS, Xu B, Rebeck GW, Hoe HS. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci. 2009;29(48):15317–15322. doi: 10.1523/JNEUROSCI.4026-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Eadie BD, Redila VA, Christie BR. Voluntary exercise alters the cytoarchitecture of the adult dentate gyrus by increasing cellular proliferation, dendritic complexity, and spine density. J Comp Neurol. 2005;486(1):39–47. doi: 10.1002/cne.20493. [DOI] [PubMed] [Google Scholar]
  18. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011;108(7):3017–3022. doi: 10.1073/pnas.1015950108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Etgen T, Sander D, Huntgeburth U, Poppert H, Forstl H, Bickel H. Physical activity and incident cognitive impairment in elderly persons: the INVADE study. Arch Intern Med. 2010;170(2):186–193. doi: 10.1001/archinternmed.2009.498. [DOI] [PubMed] [Google Scholar]
  20. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  21. Fukao K, Shimada K, Naito H, Sumiyoshi K, Inoue N, Iesaki T, Kume A, Kiyanagi T, Hiki M, Hirose K, Matsumori R, Ohsaka H, Takahashi Y, Toyoda S, Itoh S, Miyazaki T, Tada N, Daida H. Voluntary exercise ameliorates the progression of atherosclerotic lesion formation via anti-inflammatory effects in apolipoprotein E-deficient mice. J Atheroscler Thromb. 2010;17(12):1226–1236. doi: 10.5551/jat.4788. [DOI] [PubMed] [Google Scholar]
  22. Gold BT, Powell DK, Andersen AH, Smith CD. Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer’s disease. Neuroimage. 2010;52(4):1487–1494. doi: 10.1016/j.neuroimage.2010.05.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Head D, Bugg JM, Goate AM, Fagan AM, Mintun MA, Benzinger T, Holtzman DM, Morris JC. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition. Arch Neurol. 2012;69(5):636–643. doi: 10.1001/archneurol.2011.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Heise V, Filippini N, Ebmeier KP, Mackay CE. The APOE varepsilon4 allele modulates brain white matter integrity in healthy adults. Mol Psychiatry. 2011;16(9):908–916. doi: 10.1038/mp.2010.90. [DOI] [PubMed] [Google Scholar]
  25. Honea RA, Vidoni E, Harsha A, Burns JM. Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis. 2009;18(3):553–564. doi: 10.3233/JAD-2009-1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Intlekofer KA, Cotman CW. Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol Dis. 2013;57:47–55. doi: 10.1016/j.nbd.2012.06.011. [DOI] [PubMed] [Google Scholar]
  27. Johnson NF, Kim C, Clasey JL, Bailey A, Gold BT. Cardiorespiratory fitness is positively correlated with cerebral white matter integrity in healthy seniors. Neuroimage. 2012;59(2):1514–1523. doi: 10.1016/j.neuroimage.2011.08.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jurica PJ, Leittten CL, Mattis S. Dementia Rating Scale-2 professional manual. Lutz, FL: Psychological Assessment Resources; 2001. [Google Scholar]
  29. Lane RM, Farlow MR. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer’s disease. J Lipid Res. 2005;46(5):949–968. doi: 10.1194/jlr.M400486-JLR200. [DOI] [PubMed] [Google Scholar]
  30. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–186. [PubMed] [Google Scholar]
  31. Marks BL, Katz LM, Styner M, Smith JK. Aerobic fitness and obesity: relationship to cerebral white matter integrity in the brain of active and sedentary older adults. Br J Sports Med. 2011;45(15):1208–1215. doi: 10.1136/bjsm.2009.068114. [DOI] [PubMed] [Google Scholar]
  32. Marks BL, Madden DJ, Bucur B, Provenzale JM, White LE, Cabeza R, Huettel SA. Role of aerobic fitness and aging on cerebral white matter integrity. Ann N Y Acad Sci. 2007;1097:171–174. doi: 10.1196/annals.1379.022. [DOI] [PubMed] [Google Scholar]
  33. Matura S, Prvulovic D, Jurcoane A, Hartmann D, Miller J, Scheibe M, O’Dwyer L, Oertel-Knochel V, Knochel C, Reinke B, Karakaya T, Fusser F, Pantel J. Differential effects of the ApoE4 genotype on brain structure and function. Neuroimage. 2014;89:81–91. doi: 10.1016/j.neuroimage.2013.11.042. [DOI] [PubMed] [Google Scholar]
  34. Mori S, Oishi K, Jiang H, Jiang L, Li X, Akhter K, Hua K, Faria AV, Mahmood A, Woods R, Toga AW, Pike GB, Neto PR, Evans A, Zhang J, Huang H, Miller MI, van Zijl P, Mazziotta J. Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage. 2008;40(2):570–582. doi: 10.1016/j.neuroimage.2007.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Nichol K, Deeny SP, Seif J, Camaclang K, Cotman CW. Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement. 2009;5(4):287–294. doi: 10.1016/j.jalz.2009.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nierenberg J, Pomara N, Hoptman MJ, Sidtis JJ, Ardekani BA, Lim KO. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. Neuroreport. 2005;16(12):1369–1372. doi: 10.1097/01.wnr.0000174058.49521.16. [DOI] [PubMed] [Google Scholar]
  37. Nyberg L, Salami A. The APOE epsilon4 allele in relation to brain white-matter microstructure in adulthood and aging. Scand J Psychol. 2014;55(3):263–267. doi: 10.1111/sjop.12099. [DOI] [PubMed] [Google Scholar]
  38. O’Dwyer L, Lamberton F, Matura S, Scheibe M, Miller J, Rujescu D, Prvulovic D, Hampel H. White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines. PLoS One. 2012;7(4):e36024. doi: 10.1371/journal.pone.0036024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Patel KT, Stevens MC, Pearlson GD, Winkler AM, Hawkins KA, Skudlarski P, Bauer LO. Default mode network activity and white matter integrity in healthy middle-aged ApoE4 carriers. Brain Imaging Behav. 2013;7(1):60–67. doi: 10.1007/s11682-012-9187-y. [DOI] [PubMed] [Google Scholar]
  40. Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, Sloan R, Gage FH, Brown TR, Small SA. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proceedings of the National Academy of Science USA. 2007;104(13):5638–5643. doi: 10.1073/pnas.0611721104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Persson J, Lind J, Larsson A, Ingvar M, Cruts M, Van Broeckhoven C, Adolfsson R, Nilsson LG, Nyberg L. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology. 2006;66(7):1029–1033. doi: 10.1212/01.wnl.0000204180.25361.48. [DOI] [PubMed] [Google Scholar]
  42. Pierpaoli C, Barnett A, Pajevic S, Chen R, Penix LR, Virta A, Basser P. Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage. 2001;13(6 Pt 1):1174–1185. doi: 10.1006/nimg.2001.0765. [DOI] [PubMed] [Google Scholar]
  43. Poirier J. Apolipoprotein E and Alzheimer’s disease. A role in amyloid catabolism. Ann N Y Acad Sci. 2000;924:81–90. doi: 10.1111/j.1749-6632.2000.tb05564.x. [DOI] [PubMed] [Google Scholar]
  44. Rao SM, Bonner-Jackson A, Nielson KA, Seidenberg M, Smith JC, Woodard JL, Durgerian S. Genetic risk for Alzheimer’s disease alters the five-year trajectory of semantic memory activation in cognitively intact elders. Neuroimage. 2015;111C:136–146. doi: 10.1016/j.neuroimage.2015.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Reiman EM, Langbaum JB, Tariot PN. Alzheimer’s prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med. 2010;4(1):3–14. doi: 10.2217/bmm.09.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rey A. L’examen clinique en psychologie. Paris: Presses Universitaires de France; 1958. [Google Scholar]
  47. Sager MA, Hermann B, La Rue A. Middle-aged children of persons with Alzheimer’s disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer’s Prevention. J Geriatr Psychiatry Neurol. 2005;18(4):245–249. doi: 10.1177/0891988705281882. [DOI] [PubMed] [Google Scholar]
  48. Saunders AM, Hulette O, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR, Alberts MJ, Strittmatter WJ, Breitner JC, Rosenberg C. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer’s disease. Lancet. 1996;348(9020):90–93. doi: 10.1016/s0140-6736(96)01251-2. [DOI] [PubMed] [Google Scholar]
  49. Schuit AJ, Feskens EJ, Launer LJ, Kromhout D. Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc. 2001;33(5):772–777. doi: 10.1097/00005768-200105000-00015. [DOI] [PubMed] [Google Scholar]
  50. Smith CD, Chebrolu H, Andersen AH, Powell DA, Lovell MA, Xiong S, Gold BT. White matter diffusion alterations in normal women at risk of Alzheimer’s disease. Neurobiol Aging. 2010;31(7):1122–1131. doi: 10.1016/j.neurobiolaging.2008.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Smith JC, Nielson KA, Antuono P, Lyons JA, Hanson RJ, Butts AM, Hantke NC, Verber MD. Semantic memory functional MRI and cognitive function after exercise intervention in mild cognitive impairment. J Alzheimers Dis. 2013;37(1):197–215. doi: 10.3233/JAD-130467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Smith JC, Nielson KA, Woodard JL, Seidenberg M, Durgerian S, Antuono P, Butts AM, Hantke NC, Lancaster MA, Rao SM. Interactive effects of physical activity and APOE-epsilon4 on BOLD semantic memory activation in healthy elders. Neuroimage. 2011;54(1):635–644. doi: 10.1016/j.neuroimage.2010.07.070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Smith JC, Nielson KA, Woodard JL, Seidenberg M, Durgerian S, Hazlett KE, Figueroa CM, Kandah CC, Kay CD, Matthews MA, Rao SM. Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer’s disease. Frontiers in Aging Neuroscience. 2014;6(61):1–7. doi: 10.3389/fnagi.2014.00061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143–155. doi: 10.1002/hbm.10062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Smith SM, Jenkinson M, Johansen-Berg H, Ruckert D, Nichols TE, Mackay CE. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. NeuroImage. 2006;31:1487–1505. doi: 10.1016/j.neuroimage.2006.02.024. [DOI] [PubMed] [Google Scholar]
  56. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage. 2002;17(3):1429–1436. doi: 10.1006/nimg.2002.1267. [DOI] [PubMed] [Google Scholar]
  57. Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer’s disease: implications for prevention trials. Neuron. 2014;84(3):608–622. doi: 10.1016/j.neuron.2014.10.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Taylor-Piliae RE, Fair JM, Haskell WL, Varady AN, Iribarren C, Hlatky MA, Go AS, Fortmann SP. Validation of the Stanford Brief Activity Survey: examining psychological factors and physical activity levels in older adults. J Phys Act Health. 2010;7(1):87–94. doi: 10.1123/jpah.7.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Taylor-Piliae RE, Haskell WL, Iribarren C, Norton LC, Mahbouba MH, Fair JM, Hlatky MA, Go AS, Fortmann SP. Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. J Cardiopulm Rehabil Prev. 2007;27(4):227–232. doi: 10.1097/01.HCR.0000281768.97899.bb. [DOI] [PubMed] [Google Scholar]
  60. Taylor-Piliae RE, Norton LC, Haskell WL, Mahbouda MH, Fair JM, Iribarren C, Hlatky MA, Go AS, Fortmann SP. Validation of a new brief physical activity survey among men and women aged 60–69 years. American Journal of Epidemiology. 2006;164(6):598–606. doi: 10.1093/aje/kwj248. [DOI] [PubMed] [Google Scholar]
  61. Tian Q, Erickson KI, Simonsick EM, Aizenstein HJ, Glynn NW, Boudreau RM, Newman AB, Kritchevsky SB, Yaffe K, Harris TB, Rosano C. Physical activity predicts microstructural integrity in memory-related networks in very old adults. J Gerontol A Biol Sci Med Sci. 2014a;69(10):1284–1290. doi: 10.1093/gerona/glt287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Tian Q, Simonsick EM, Erickson KI, Aizenstein HJ, Glynn NW, Boudreau RM, Newman AB, Kritchevsky SB, Yaffe K, Harris T, Rosano C Health A.B.C.s. Cardiorespiratory fitness and brain diffusion tensor imaging in adults over 80 years of age. Brain Res. 2014b;1588:63–72. doi: 10.1016/j.brainres.2014.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci. 2001;21(5):1628–1634. doi: 10.1523/JNEUROSCI.21-05-01628.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Tseng BY, Gundapuneedi T, Khan MA, Diaz-Arrastia R, Levine BD, Lu H, Huang H, Zhang R. White matter integrity in physically fit older adults. Neuroimage. 2013;82:510–516. doi: 10.1016/j.neuroimage.2013.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. van Praag H, Shubert T, Zhao C, Gage FH. Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci. 2005;25(38):8680–8685. doi: 10.1523/JNEUROSCI.1731-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Voss MW, Heo S, Prakash RS, Erickson KI, Alves H, Chaddock L, Szabo AN, Mailey EL, Wojcicki TR, White SM, Gothe N, McAuley E, Sutton BP, Kramer AF. The influence of aerobic fitness on cerebral white matter integrity and cognitive function in older adults: Results of a one-year exercise intervention. Hum Brain Mapp. 2012 doi: 10.1002/hbm.22119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Woodard JL, Seidenberg M, Nielson KA, Antuono P, Guidotti L, Durgerian S, Zhang Q, Lancaster M, Hantke N, Butts A, Rao SM. Semantic memory activation in amnestic mild cognitive impairment. Brain. 2009;132(Pt 8):2068–2078. doi: 10.1093/brain/awp157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Woodard JL, Seidenberg M, Nielson KA, Smith JC, Antuono P, Durgerian S, Guidotti L, Zhang Q, Butts A, Hantke N, Lancaster M, Rao SM. Prediction of cognitive decline in healthy older adults using fMRI. Journal of Alzheimer’s Disease. 2010;21:871–885. doi: 10.3233/JAD-2010-091693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Woodard JL, Sugarman MA, Nielson KA, Smith JC, Seidenberg M, Durgerian S, Butts A, Hantke N, Lancaster M, Matthews MA, Rao SM. Lifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy aging. Curr Alzheimer Res. 2012;9(4):436–446. doi: 10.2174/156720512800492477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24(4):709–711. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
2

RESOURCES